American Society of Hematology

SHERPA: Blue

People

  1. Sadelain
    Sadelain
  2. O'Reilly
    O'Reilly
  3. Curran
    Curran
  4. Kernan
    Kernan
  5. Van Den Brink
    Van Den Brink
  6. Park
    Park
  7. Selvakumar
    Selvakumar
  8. Hanash
    Hanash
  9. Scaradavou
    Scaradavou
  10. Shukla
    Shukla

Groups

  1. Center for Hematologic Malignancies (27)
  2. Department of Medicine (27)
  3. GSK Faculty (27)
  4. Hematologic Malignancies Research (27)
  5. Hematologic Malignancies, Division of (27)
  6. Immunology Program Faculty (27)
  7. Molecular Pharmacology and Chemistry Program Faculty (27)
  8. Sloan Kettering Institute Faculty (27)
  9. Pediatrics, Department of (20)
  10. Stem Cell Transplantation and Cellular Therapy Service (20)
Search Within
  1. "Immunology Program Faculty"
  2. "Sloan Kettering Institute Faculty"
  3. "Michel Sadelain"
  4. "Meeting abstract"
Formats
  1. Meeting Abstract (27)
Groups
  1. Center for Hematologic Malignancies (27)
  2. Department of Medicine (27)
  3. GSK Faculty (27)
  4. Hematologic Malignancies Research (27)
  5. Hematologic Malignancies, Division of (27)
  6. Immunology Program Faculty (27)

More Groups

People
  1. Michel Sadelain (27)
  2. Richard O'Reilly (20)
  3. Isabelle Riviere (10)
  4. Marcel Van Den Brink (7)
  5. Renier Brentjens (7)
  6. Guenther Koehne (6)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (1)
  6. 2014 (1)

More Years

Publications
  1. Blood (27)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Murine donor 1928z CAR T cells exert potent graft-versus-lymphoma activity without graft-versus-host-disease
    Meeting Abstract

    Smith, M.; Ghosh, A.; James, S.; Davila, M. L.; Velardi, E.; Argyropoulos, K. V.; Gunset, G.; Schietinger, A.; Sadelain, M. W.; van den Brink, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Multi-center clinical trial of CAR T cells in pediatric/young adult patients with relapsed B-cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Silverman, L. B.; Kobos, R.; Shukla, N.; Steinherz, P. G.; Boulad, F.; Prockop, S.; Scaradavou, A.; Margossian, S. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells targeting the CD19 antigen for the treatment of pediatric relapsed B cell ALL
    Meeting Abstract

    Curran, K. J.; Riviere, I.; Kobos, R.; Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Renaud, T. M.; Shukla, N.; Steinherz, P. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • CD19-targeted donor T cells exert potent graft versus lymphoma activity and attenuated GVHD
    Meeting Abstract

    Ghosh, A.; Davila, M. L.; Young, L. F.; Kloss, C.; Gunset, G.; Smith, O. M.; West, M. L.; Singer, N. V.; Holland, A. M.; Jenq, R. R.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • CD19 targeted allogeneic EBV-specific T cells for the treatment of relapsed ALL in pediatric patients post HSCT
    Meeting Abstract

    Curran, K. J.; Kernan, N. A.; Wang, X. Y.; Taylor, C.; Doubrovina, E.; Bartido, S.; Sadelain, M.; O'Reilly, R. J.; Brentjens, R. J.; Riviere, I.
    Blood (2012)

    Fulltext@MSK | Save
  • Over-expression of TRAIL on donor T cells enhances GVT and suppresses gvhd via elimination of alloreactive T cells and host APC
    Meeting Abstract

    Ghosh, A.; Dogan, Y.; Holland, A. M.; Smith, O. M.; Young, L. F.; West, M. L.; Singer, N. V.; Jenq, R. R.; Na, I. K.; Penack, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Genetic engineering of donor T cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J.; more...
    Blood (2010)

    Fulltext@MSK | Save